Stay updated on Lenvatinib and Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in HCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    - Padua, Italy, 35128 was replaced by Padova, Italy, 35128 in the locations list.
    Difference
    0.0%
    Check dated 2026-04-09T08:31:06.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added the disease term Hepatocellular carcinoma and a Resources section linking to the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T17:48:09.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:56:09.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Plain Language Summary added and page updated to Revision 3.4.2 with new dates; funding-status notice removed.
    Difference
    0.3%
    Check dated 2026-02-11T09:21:20.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the site to revision v3.4.1. These changes are administrative and do not modify the trial details, eligibility criteria, endpoints, or study data.
    Difference
    0.2%
    Check dated 2026-02-04T05:52:26.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Show glossary is now displayed; Last Update Submitted that Met QC Criteria and Last Update Posted timestamps are displayed; No FEAR Act Data is shown and Revision indicator updated to v3.4.0. The previous items Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.1%
    Check dated 2026-01-28T04:15:47.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.